Literature DB >> 9041343

Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C.

F L Dumoulin1, A Bach, L Leifeld, M El-Bakri, H P Fischer, T Sauerbruch, U Spengler.   

Abstract

In order to characterize intrahepatic cytokine production, the mRNA levels of interleukin (IL)-2, -4, and -10 and interferon (IFN)-gamma were semiquantitatively determined by reverse-transcription competitive polymerase chain reaction in liver specimens from patients with chronic hepatitis C (n = 23), chronic hepatitis B (n = 9), or primary biliary cirrhosis (n = 12) and normal liver (control) specimens (n = 12). IL-4 mRNA was undetectable. Similar IL-10 mRNA levels were detected in all samples studied, including the controls. Mean IFN-gamma and IL-2 mRNA levels were elevated in chronic inflammatory liver disease. IL-2 mRNA levels were similar in all 3 patient groups, but intrahepatic IFN-gamma mRNA levels were significantly higher in chronic hepatitis C than in chronic hepatitis B or primary biliary cirrhosis patients. This predominance of IFN-gamma may indicate a lower susceptibility of hepatitis C virus to the antiviral effects of this cytokine. The presence of IL-10 in normal liver may impair the induction of antiviral immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041343     DOI: 10.1093/infdis/175.3.681

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

2.  Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.

Authors:  R Patzwahl; V Meier; G Ramadori; S Mihm
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection.

Authors:  S Schweyer; S Mihm; H J Radzun; H Hartmann; A Fayyazi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.

Authors:  P H McGuinness; D Painter; S Davies; G W McCaughan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.

Authors:  Ankur Goyal; P V Suneetha; G T Kumar; Deepak K Shukla; Naveen Arora; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 6.  Effector CD8 T cell trafficking within the liver.

Authors:  Luca G Guidotti; Matteo Iannacone
Journal:  Mol Immunol       Date:  2012-11-10       Impact factor: 4.407

7.  The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.

Authors:  C Goulding; R McManus; A Murphy; G MacDonald; S Barrett; J Crowe; J Hegarty; S McKiernan; D Kelleher
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

8.  High expression of APOBEC3G in patients infected with hepatitis C virus.

Authors:  Yoshihiro Komohara; Hirohisa Yano; Shigeki Shichijo; Kunitada Shimotohno; Kyogo Itoh; Akira Yamada
Journal:  J Mol Histol       Date:  2006-10-12       Impact factor: 2.611

9.  Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride.

Authors:  G Sparmann; S Behrend; J Merkord; H D Kleine; E Graser; T Ritter; S Liebe; J Emmrich
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

10.  Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis.

Authors:  Javier Crespo; Montserrat Rivero; Emilio Fábrega; Amalía Cayón; José Antonio Amado; Maria Teresa García-Unzeta; Fernando Pons-Romero
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.